UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Call Option (Right to Buy) | Â (2) | Â (3) | Series A Preferred Stock | 150,000 (4) | $ 105 | D (1) | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Coliseum Capital Co-Invest, L.P. METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH STAMFORD, CT 06902 |
 X |  X |  |  |
Coliseum Capital Co-Invest, L.P., By: Coliseum Capital, LLC, its General Partner, By: Christopher Shackelton, Manager | 10/28/2014 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The Option was issued to Coliseum Capital Capital Co-Invest, L.P. ("CCC"), Coliseum Capital Partners, L.P., Coliseum Capital Partners II, L.P. and Blackwell Partners, LLC. CCC disclaims beneficial ownership of the Option, except to the extent of its pecuniary interest therein. |
(2) | Immediately following the consummation of the Issuer's expected rights offering. |
(3) | 30 days following the consummation of the Issuer's expected rights offering. |
(4) | The 150,000 shares of Series A Preferred Stock is convertible into 376,126 shares of Common Stock at a conversion price of $39.88 per share. |
 Remarks: The Reporting Person may be deemed to be a member of a Section 13(d) "group" consisting of Christopher Shackelton ("Shackelton"), Coliseum Capital, LLC ("CC"), Coliseum Capital Partners, L.P.("CCP"), Coliseum Capital Partners II, L.P. ("CCP2"), Coliseum Capital Management, LLC ("CCM"), Blackwell Partners, LLC ('Blackwell"), Coliseum Capital Co-Invest, L.P. ("CCC") and Adam Gray ("Gray").  Shackelton is a director of the Issuer. As a result, CC, CCP, CCP2, CCM, Blackwell, CCC and Gray may be deemed to be directors by deputization of the Issuer solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. |